LB
63
22
LLY
37
-3
R
71
4
MPC
44
-3
AAP
24
6
JWN
48
6
IPG
56
3
BA
54
5
TGT
22
2
VRSN
53
-4
WBA
48
4
BMY
60
2
VNO
60
10
PBI
69
4
GT
62
6
VTR
47
-7
GOOGL
40
-5
DG
6
2
ES
34
3
M
37
12
LB
63
22
LLY
37
-3
R
71
4
MPC
44
-3
AAP
24
6
JWN
48
6
IPG
56
3
BA
54
5
TGT
22
2
VRSN
53
-4
WBA
48
4
BMY
60
2
VNO
60
10
PBI
69
4
GT
62
6
VTR
47
-7
GOOGL
40
-5
DG
6
2
ES
34
3
M
37
12
Financhill
Back

Apellis Pharmaceuticals Vs. Cassava Sciences Industry Stock Comparison

Sell
48

APLS
Apellis Pharmaceuticals

Last Price:
30.76
Seasonality Move:
16.11%
Sell
44

SAVA
Cassava Sciences

Last Price:
26.49
Seasonality Move:
47.33%
Sell
48
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $30.77. The Score for APLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Cassava Sciences (SAVA) is a Sell

Is Cassava Sciences a Buy, Sell or Hold?

  • The current Cassava Sciences [SAVA] share price is $26.48. The Score for SAVA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • SAVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $30.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

SAVA Stock Price Chart

What is Cassava Sciences's stock price today?

  • The Cassava Sciences share price today is $26.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 59.23 Buy
Chaikin Money Flow: 2322513 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.9 - 29.12) Buy
Bollinger Bands (100): (28.55 - 38.61) Sell

SAVA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.25 Buy
Relative Strength Index (14 RSI): 48.47 Sell
Chaikin Money Flow: -6063678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.34 - 28.38) Sell
Bollinger Bands (100): (18.2 - 31.22) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.97 Buy
20-day SMA: 28.22 Buy
50-day SMA: 29.11 Buy
200-day SMA: 42.36 Sell
8-day EMA: 28.48 Buy
20-day EMA: 28.34 Buy
50-day EMA: 29.88 Buy
200-day EMA: 39.46 Sell

SAVA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.36 Sell
20-day SMA: 26.61 Sell
50-day SMA: 27.53 Sell
200-day SMA: 22.94 Buy
8-day EMA: 27.63 Sell
20-day EMA: 27.15 Sell
50-day EMA: 26.83 Sell
200-day EMA: 24.24 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.

Cassava Sciences Earnings Growth & SAVA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.59 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cassava Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):